IDH1 Gene Mutations: A New Paradigm in Glioma Prognosis and Therapy?

  • Labussiere M
  • Sanson M
  • Idbaih A
  • et al.
48Citations
Citations of this article
75Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The manuscript examines the role of isocitrate dehydrogenase 1 and the IDH1 gene in the prognosis and therapy of glial tumors.

References Powered by Scopus

An integrated genomic analysis of human glioblastoma multiforme

4969Citations
N/AReaders
Get full text

IDH1 and IDH2 mutations in gliomas

4907Citations
N/AReaders
Get full text

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

3107Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Isocitrate dehydrogenase mutation is associated with tumor location and magnetic resonance imaging characteristics in astrocytic neoplasms

153Citations
N/AReaders
Get full text

Targeting cancer metabolism

131Citations
N/AReaders
Get full text

Correlation of IDH1 mutation with clinicopathologic factors and prognosis in primary glioblastoma: A report of 118 patients from China

123Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Labussiere, M., Sanson, M., Idbaih, A., & Delattre, J.-Y. (2010). IDH1 Gene Mutations: A New Paradigm in Glioma Prognosis and Therapy? The Oncologist, 15(2), 196–199. https://doi.org/10.1634/theoncologist.2009-0218

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 35

73%

Professor / Associate Prof. 7

15%

Researcher 5

10%

Lecturer / Post doc 1

2%

Readers' Discipline

Tooltip

Medicine and Dentistry 22

43%

Agricultural and Biological Sciences 21

41%

Neuroscience 5

10%

Pharmacology, Toxicology and Pharmaceut... 3

6%

Save time finding and organizing research with Mendeley

Sign up for free